Patent · US Active

Polymorphic forms of RAD1901-2HCL

US10385008B2 · kind B2 · utility

2Cited by
59References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 5, 2018
Grant dateAug 20, 2019
Priority date
Expiry dateJan 5, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Various polymorphic forms of RAD1901-2HCl, including three crystalline and amorphous forms, are prepared and characterized. Uses of the various polymorphic forms of RAD1901-2HCl for cancer treatment are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.